Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPV with ILM Peeling vs Conbercept for Treatment-naïve DME
NCT05728476Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Mar 2024
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: Best Corrected Visual Acuity change at 12 months and Central Subfield Thickness change at 12 months. Started Mar 2024; status: recruiting.
Beyond the preview
Go deeper on NCT05728476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728476.